The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers (Q70177471)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 1983

Language	Label	Description	Also known as
English	The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers	scientific article published on 01 August 1983

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

author name string

S. B. Reele

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316420

26 September 2023

O. V. Miller

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316420

26 September 2023

C. Spillers

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316420

26 September 2023

R. R. Gorman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316420

26 September 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6316420

26 September 2023

publication date

1 August 1983

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

full work available at URL

https://api.elsevier.com/content/article/PII:0090698083900965?httpAccept=text/xml

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

https://api.elsevier.com/content/article/PII:0090698083900965?httpAccept=text/plain

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

287-302

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

1

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

2

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1α on the rat gastric mucosa in vivo and in vitro

3

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Effects of prostacyclin (PGI2), 6-oxo-PGF1 alpha and PGE2 on sympathetic nerve function in mesenteric arteries and veins of the rabbit in vitro

4

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Actions of prostacyclin (PGI2) on adrenergic neuroeffector transmission in the rabbit kidney

5

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man

6

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Haemodynamic changes induced by prostacyclin in man.

7

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels

8

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Effects of intravenous infusion of prostacyclin (PGI2) in man

9

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men

10

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin infusion during cardiopulmonary bypass in man.

11

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin administration during cardiopulmonary bypass in man.

12

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure

13

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Salutary effects of prostacyclin in endotoxic shock

14

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin reversal of lethal endotoxemia in dogs

15

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease

17

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Prostacyclin therapy in peripheral arterial disease

18

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease

19

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?

20

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Increased platelet activity after termination of prostacyclin infusion into man

21

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man

25

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)

26

1 reference

10.1016/0090-6980(83)90096-5

https://api.crossref.org/works/10.1016/0090-6980(83)90096-5

26 September 2023

Identifiers

10.1016/0090-6980(83)90096-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6316420%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70177471&oldid=1981764318"